Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies because of its high invasiveness and metastatic potential. Computed tomography (CT) is often used as a preliminary diagnostic tool for pancreatic cancer, and it is increasingly used to predict treatment response and disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jian, Liu, Ying, Liu, Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730437/
https://www.ncbi.nlm.nih.gov/pubmed/36504551
http://dx.doi.org/10.3748/wjg.v28.i44.6310
_version_ 1784845670504464384
author Yang, Jian
Liu, Ying
Liu, Shi
author_facet Yang, Jian
Liu, Ying
Liu, Shi
author_sort Yang, Jian
collection PubMed
description Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies because of its high invasiveness and metastatic potential. Computed tomography (CT) is often used as a preliminary diagnostic tool for pancreatic cancer, and it is increasingly used to predict treatment response and disease stage. Recently, a study published in World Journal of Gastroenterology reported that quantitative analysis of preoperative enhanced CT data can be used to predict postoperative overall survival in patients with PDAC. A tumor relative enhancement ratio of ≤ 0.7 indicates a higher tumor stage and poor prognosis.
format Online
Article
Text
id pubmed-9730437
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-97304372022-12-09 Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer” Yang, Jian Liu, Ying Liu, Shi World J Gastroenterol Letter to the Editor Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies because of its high invasiveness and metastatic potential. Computed tomography (CT) is often used as a preliminary diagnostic tool for pancreatic cancer, and it is increasingly used to predict treatment response and disease stage. Recently, a study published in World Journal of Gastroenterology reported that quantitative analysis of preoperative enhanced CT data can be used to predict postoperative overall survival in patients with PDAC. A tumor relative enhancement ratio of ≤ 0.7 indicates a higher tumor stage and poor prognosis. Baishideng Publishing Group Inc 2022-11-28 2022-11-28 /pmc/articles/PMC9730437/ /pubmed/36504551 http://dx.doi.org/10.3748/wjg.v28.i44.6310 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Letter to the Editor
Yang, Jian
Liu, Ying
Liu, Shi
Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”
title Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”
title_full Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”
title_fullStr Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”
title_full_unstemmed Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”
title_short Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”
title_sort comment on “prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730437/
https://www.ncbi.nlm.nih.gov/pubmed/36504551
http://dx.doi.org/10.3748/wjg.v28.i44.6310
work_keys_str_mv AT yangjian commentonprognosticvalueofpreoperativeenhancedcomputedtomographyasaquantitativeimagingbiomarkerinpancreaticcancer
AT liuying commentonprognosticvalueofpreoperativeenhancedcomputedtomographyasaquantitativeimagingbiomarkerinpancreaticcancer
AT liushi commentonprognosticvalueofpreoperativeenhancedcomputedtomographyasaquantitativeimagingbiomarkerinpancreaticcancer

Ejemplares similares